Evidence map›Paper›PMID 24486527›Full record

ReviewFEBS letters2014

Degradation of connexins and gap junctions.

Matthias M Falk, Rachael M Kells, Viviana M Berthoud

Abstract readReview
In one paragraph

Review in FEBS letters, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 61 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
61citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

61 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Frontiers in cellular and infection microbiology · 2026
    Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Targeting Autophagy in Atrial Fibrillation.Reviews in cardiovascular medicine · 2023
    Review
  19. Article
  20. Article

1 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Matthias M FalkDepartment of Biological Sciences, Lehigh University, 111 Research Drive, Iacocca Hall, D-218, Bethlehem, PA 18015, USA. Electronic address: mmf4@lehigh.edu.
Rachael M KellsDepartment of Biological Sciences, Lehigh University, 111 Research Drive, Iacocca Hall, D-218, Bethlehem, PA 18015, USA.
Viviana M BerthoudDepartment of Pediatrics, University of Chicago, 900 East 57th St., KCBD, Room 5150, Chicago, IL 60637, USA. Electronic address: vberthou@peds.bsd.uchicago.edu.

Funding

Re-Engineering Translational Research at the University of ChicagoUL1TR000430 · NCATS · UNIVERSITY OF CHICAGO · PI SOLWAY, JULIAN · 2012 to 2016
$20.2M
BIOLOGY OF LENS INTERCELLULAR COMMUNICATIONR01EY008368 · NEI · WASHINGTON UNIVERSITY · PI BEYER, ERIC C · 1995 to 2018
$7.1M
SYNTHESIS AND MATURATION OF OLIGOMERIC MEMBRANE PROTEINSR01GM055725 · NIGMS · SCRIPPS RESEARCH INSTITUTE · PI FALK, MATTHIAS M · 1998 to 2013
$2.5M
NCATS NIH HHS UL1 TR000430NEI NIH HHS R01 EY008368NEI NIH HHS R01-EY08368NIGMS NIH HHS R01 GM055725NIGMS NIH HHS R01-GM55725-13
6 · The paper itself

Abstract

Connexin proteins are short-lived within the cell, whether present in the secretory pathway or in gap junction plaques. Their levels can be modulated by their rate of degradation. Connexins, at different stages of assembly, are degraded through the proteasomal, endo-/lysosomal, and phago-/lysosomal pathways. In this review, we summarize the current knowledge about connexin and gap junction degradation including the signals and protein-protein interactions that participate in their targeting for degradation.

Indexed as

ProteolysisAnimalsConnexinsEndosomesGap JunctionsHumansLysosomesProteasome Endopeptidase ComplexUbiquitinationConnexinsProteasome Endopeptidase ComplexAutophagosomeConnexinGap junctionLysosomeProteasomeUbiquitin

Identifiers

PMID24486527
PMCPMC3989500

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.